Search

NEW YORK, Jan 29, 2015 (GLOBE NEWSWIRE via COMTEX) -- Levi & Korsinsky notifies investors of NPS Pharmaceuticals Inc. ('NPS Pharmaceuticals' or 'the Company') (Nasdaq:NPSP) of claims of breaches of [...]

ENPNewswire-January 26, 2015--Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA (parathyroid hormone) (C)2015 ENPublishing - http://www.enpublishing.co.uk ENP Newswire - 25 January 2015 Release date- 23012015 [...]

Shire plc notes the announcement today by NPS Pharmaceuticals, Inc. that the U.S. Food and Drug Administration (FDA) has approved NATPARA (parathyroid hormone) as an adjunct to calcium and vitamin [...]

First FDA-approved parathyroid hormone for hypoparathyroidism Supported by largest clinical program ever conducted in patients with hypoparathyroidism BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and [...]

DUBLIN, Jan. 23, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) notes the announcement today by NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) that the U.S. Food and Drug Administration (FDA) [...]

Jan 14, 2015 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- NPS Pharmaceuticals (NASDAQ:NPSP) was downgraded from Overweight to Neutral at JP Morgan today. The stock closed yesterday at $45.54 on volume of [...]

Jan 13, 2015 (Marketintelligencecenter.com via COMTEX) -- NPS Pharmaceuticals Inc (NPSP) is a good candidate for a covered call at the $41.00 level. The May. '15 call at that price [...]

Shire Plc declared concerning the NPS Pharmaceuticals Inc buyout, under USD 5.2 billion deal in an attempt to beef up its position in the money-spinning medicines field for rare diseases. [...]

DALLAS -- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors [...]

Washington, DC, Jan 12, 2015 (MidnightTrader via COMTEX) -- Biopharmaceutical company NPS Pharmaceuticals, Inc. (NPSP) has been downgraded by analysts at Canaccord Genuity to a hold rating from a buy. [...]

Byline: Laura Board To view this article on the web, click here: http://www.thestreet.com/story/13007316/1/shire-agrees-to-pay-52-billion-for-nps-pharmaceuticals.html Irish pharmaceuticals company Shire plc (SHPG) on Sunday, Jan. 11, said it had agreed to pay about [...]

Byline: Jamie Hodge To view this article on the web, click here: http://www.thestreet.com/story/13006998/1/heavy-early-morning-activity-on-nps-pharmaceuticals-npsp.html Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of [...]

Byline: Chris Dow To view this article on the web, click here: http://www.thestreet.com/story/13007839/1/3-stocks-moving-the-health-care-sector-upward.html Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of [...]

(EDGAR Online via COMTEX) -- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of [...]

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, January 12, 2015 /PRNewswire/ -- Moments ago, Analysts Review released new research updates concerning several important [...]

ENPNewswire-January 12, 2015--Shire to Acquire NPS Pharma as Further Step in Building a Leading Biotech (C)2015 ENPublishing - http://www.enpublishing.co.uk ENP Newswire - 12 January 2015 Release date- 11012015 - Dublin, [...]

Jan 09, 2015 (Marketintelligencecenter.com via COMTEX) -- NPS Pharmaceuticals Inc (NPSP) was selected by MarketIntelligenceCenter.comaEUR(TM)s trade-picking algorithms today after trading between $41.02 and $42.95 on Thursday before closing at $42.92. [...]

Jan 08, 2015 (Marketintelligencecenter.com via COMTEX) -- A covered call identified by MarketIntelligececenter.com's patented algorithms on NPS Pharmaceuticals Inc (NPSP) could yield about 13.17% (37.84% annualized, for comparison purposes only) [...]

Editor Note: For more information about this release, please scroll to bottom. LONDON, January 8, 2015 /PRNewswire/ -- Investor-Edge has initiated coverage on the following equities: NPS Pharmaceuticals Inc. (NASDAQ: [...]

Jan 07, 2015 (Marketintelligencecenter.com via COMTEX) -- NPS Pharmaceuticals Inc (NPSP) was selected by MarketIntelligenceCenter.comaEUR(TM)s trade-picking algorithms today after trading between $38.17 and $42.06 on Tuesday before closing at $41.06. [...]

Jan 06, 2015 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 3 months, NPS Pharmaceuticals has returned [...]

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, January 6, 2015 /PRNewswire/ -- Moments ago, Analysts Review released new research updates concerning several important [...]

Jan 05, 2015 (Marketintelligencecenter.com via COMTEX) -- After FridayaEUR(TM)s trading in NPS Pharmaceuticals Inc (NPSP) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 12.72% or 35.72% (for comparison [...]

BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the 33rd Annual J. P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2015 at 3:30 [...]

Byline: David M. Aferiat To view this article on the web, click here: http://www.thestreet.com/story/12999982/1/barbarian-at-the-gate-nps-pharmaceuticals-npsp.html Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion [...]

Jan 02, 2015 (Marketintelligencecenter.com via COMTEX) -- NPS Pharmaceuticals Inc (NPSP) closed Wednesday at $35.77 and technical indicators recently have been bullish. Based in part on those numbers, MarketIntelligenceCenter.com's patented [...]

Dec 31, 2014 (Marketintelligencecenter.com via COMTEX) -- The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on NPS Pharmaceuticals Inc (NPSP) today after it [...]

Dec 29, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 2 months, NPS Pharmaceuticals has returned [...]

Dec 26, 2014 (Marketintelligencecenter.com via COMTEX) -- After WednesdayaEUR(TM)s trading in NPS Pharmaceuticals Inc (NPSP) MarketIntelligenceCenter.com's patented algorithms uncovered a trade that offers a 13.11% return or 34.17% on an [...]

Dec 24, 2014 (Marketintelligencecenter.com via COMTEX) -- After closing Tuesday at $33.88, NPS Pharmaceuticals Inc (NPSP) presents an attractive opportunity to get a 12.87% return in just 142 days, which [...]

Dec 23, 2014 (Marketintelligencecenter.com via COMTEX) -- The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artifical Intelligence Center found a trading opportunity with NPS Pharmaceuticals Inc (NPSP) that should provide [...]

Dec 22, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 2 months, NPS Pharmaceuticals has returned [...]

Dec 19, 2014 (Marketintelligencecenter.com via COMTEX) -- MarketIntelligenceCenter.com's patented algorithms have identified an attractive covered-call trade on NPS Pharmaceuticals Inc (NPSP). Look at the May. '15 $35.00 covered call for [...]

Irish drugmaker Shire Plc is weighing a bid for US-based based rare disease specialist NPS Pharmaceuticals Inc, Bloomberg yesterday reported, citing people familiar with the matter. The move comes just [...]

Washington, DC, Dec 18, 2014 (MidnightTrader via COMTEX) -- Coverage of NPS Pharmaceuticals, Inc. (NPSP) has been resumed by analysts at Janney Capital with a neutral rating and a price [...]

Dec 16, 2014 (Marketintelligencecenter.com via COMTEX) -- The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on NPS Pharmaceuticals Inc (NPSP) that includes [...]

Dec 15, 2014 (Marketintelligencecenter.com via COMTEX) -- The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered-call trade on NPS Pharmaceuticals Inc (NPSP) that includes [...]

Dec 12, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 2 months, NPS Pharmaceuticals has returned [...]

Dec 12, 2014 (Marketintelligencecenter.com via COMTEX) -- After ThursdayaEUR(TM)s trading in NPS Pharmaceuticals Inc (NPSP) the option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center uncovered a trade that offers [...]

Dec 04, 2014 (Marketintelligencecenter.com via COMTEX) -- WednesdayaEUR(TM)s trading in NPS Pharmaceuticals Inc (NPSP) gives options traders an opportunity for a 3.15% return. By selling the Feb. '15 $31.00 call [...]

BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the Oppenheimer 25th Annual Healthcare Conference in New York on Thursday, December 11, 2014 at 9:45 a.m. ET. [...]

Byline: Scott Olson To view this article on the web, click here: http://www.thestreet.com/story/12973348/1/todays-perilous-reversal-stock-nps-pharmaceuticals-npsp.html Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of [...]

BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Medicines [...]

Nov 28, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 1 month, NPS Pharmaceuticals has returned [...]

Editor Note: For more information about this release, please scroll to bottom. LONDON, November 24, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on the following equities: Amgen Inc. (NASDAQ: AMGN), [...]

BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the Japanese Ministry [...]

Nov 20, 2014 (Marketintelligencecenter.com via COMTEX) -- For a hedged play on NPS Pharmaceuticals Inc (NPSP) MarketIntelligenceCenter.comaEUR(TM)s algorithms selected the Feb. '15 $29.00 covered call for a net debit in [...]

Nov 20, 2014 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 1 month, NPS Pharmaceuticals has returned [...]

BEDMINSTER, N.J. -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the Jefferies 2014 Global Healthcare Conference in London on Thursday, November 20, 2014 at 8:00 a.m. WET. The [...]